Balyasny Asset Management L.P.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1218710
Chicago, IL
Position in BCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,771,910
+$1,111,216 QoQ
Shares Held
186,125
+113.8% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Derivatives in BCRX
reported options exposure · as of Mar 31, 2020CallValue
$1,800,000
CallShares
900,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in BCRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,771,910 | 186,125 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $660,694 | 87,048 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,261,629 | 252,414 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,396,545 | 586,206 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,982,990 | 529,653 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $11,809,800 | 1,971,586 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,890,742 | 408,297 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $15,418,884 | 1,223,721 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $12,637,926 | 1,194,511 | Shares | Sole | 2022-08-15 | |
| 2020-03-31 | $6,011,352 | 3,005,676 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $1,800,000 | 900,000 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||